Prevention of diabetes mellitus in subjects with impaired glucose tolerance in the finnish diabetes prevention study: Results from a randomized clinical trial

Journal of the American Society of Nephrology

Volumn 14, Issue SUPPL. 2, 2003, Pages

  Lindström, Jaana ^a   Eriksson, Johan G ^a   Valle, Timo T ^a   Aunola, Sirkka ^b   Cepaitis, Zygimantas ^a   Hakumäki, Martti ^c   Hämäläinen, Helena ^b   Ilanne Parikka, Pirjo ^d   Keinänen Kiukaanniemi, Sirkka ^e   Laakso, Mauri ^f   Louheranta, Anne ^c   Mannelin, Marjo ^f   Martikkala, Vesa ^a   Moltchanov, Vladislav ^f   Rastas, Merja ^b   Salminen, Virpi ^g   Sundvall, Jouko ^a   Uusitupa, Matti ^c   Tuomilehto, Jaakko ^a,h  

^a NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

^b SOCIAL INSURANCE INSTITUTION   (Finland)

^c UNIVERSITY OF EASTERN FINLAND   (Finland)

^d Finnish Diabetes Association   (Finland)

^e UNIVERSITY OF OULU   (Finland)

^f OULU DEACONESS INSTITUTE   (Finland)

^g Institute of Nursing and Health Care   (Finland)

^h UNIVERSITY OF HELSINKI   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLESTEROL; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; SATURATED FATTY ACID; TRIACYLGLYCEROL;

ADULT; BODY MASS; CLINICAL TRIAL; CONFERENCE PAPER; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORRELATION ANALYSIS; DIETARY FIBER; FEASIBILITY STUDY; FEMALE; FINLAND; FOLLOW UP; GLUCOSE BLOOD LEVEL; HEALTH PROGRAM; HIGH RISK POPULATION; HUMAN; IMPAIRED GLUCOSE TOLERANCE; INCIDENCE; LIFESTYLE; LOW FAT DIET; MAJOR CLINICAL STUDY; MALE; METABOLIC PARAMETERS; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; ORAL GLUCOSE TOLERANCE TEST; OUTCOMES RESEARCH; PATIENT COUNSELING; PHYSICAL ACTIVITY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RISK ASSESSMENT; RISK FACTOR; SITTING; WEIGHT REDUCTION;

EID: 0037530417     PISSN: 10466673     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (21)

1. Neel JV: Diabetes mellitus: A "thrifty" genotype rendered detrimental by progress? Am J Hum Genet 14: 353-362, 1962
2. Tuomilehto J, Wolf E: Primary prevention of diabetes mellitus. Diabetes Care 10: 238-248, 1987
3. King H, Dowd JE: Primary prevention of type 2 (non-insulin-dependent) diabetes mellitus. Diabetologia 33: 3-8, 1990
4. Tuomilehto J, Tuomilehto-Wolf E, Zimmet P, Alberti K, Knowler W: Primary prevention of diabetes mellitus. In: International Textbook of Diabetes Mellitus, 2nd Ed., edited by Alberti K, Zimmet P, DeFronzo R, Keen H, New York, Wiley, 1997, pp 1799-1827
5. Hamman RF: Genetic and environmental determinants of non-insulin-dependent diabetes mellitus (NIDDM). Diabetes Metab Rev 8: 287-338, 1992
6. Zimmet PZ: Primary prevention of diabetes mellitus. Diabetes Care 11: 258-262, 1988
7. Stern MP: Primary prevention of type II diabetes mellitus. Diabetes Care 14: 399-410, 1991
8. Ohlson LO, Larsson B, Björntorp P, Eriksson H, Svardsudd K, Welin L, Tibblin G, Wilhelmsen L: Risk factors for type 2 (non-insulin-dependent) diabetes mellitus: Thirteen and one-half years of follow-up of the participants in a study of Swedish men born in 1913. Diabetologia 31: 798-805, 1988
9. Manson JE, Rimm EB, Stampfer MJ, Colditz GA, Willett WC, Krolewski AS, Rosner B, Hennekens CH, Speizer FE: Physical activity and incidence of non-insulin-dependent diabetes mellitus in women. Lancet 338: 774-778, 1991
10. The DECODE Study Group: Glucose tolerance and mortality: Comparison of WHO and American Diabetes Association diagnostic criteria. Lancet 354: 617-621, 1999
11. Tuomilehto J, Lindstrom J, Eriksson JG, Valle TT, Hamalainen H, Ilanne-Parikka P, Keinanen-Kiukaanniemi S, Laakso M, Louheranta A, Rastas M, Salminen V, Uusitupa M: Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med 344: 1343-1350, 2001
12. Chiasson J-L, Josse RG, Gomis R, Hanefeld M, Karasik A, Laakso M, STOP-NIDDM Trail Research G: Acarbose for prevention of type 2 diabetes mellitus: the STOP-NIDDM randomised trial. Lancet 359: 2072-2077, 2002
13. Knowler WC, Barrett-Connor E, Fowler SE, Hamman RF, Lachin JM, Walker EA, Nathan DM: Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med 346: 393-403, 2002
14. Eriksson J, Lindstrom J, Valle T, Aunola S, Hamalainen H, Ilanne-Parikka P, Keinanen-Kiukaanniemi S, Laakso M, Lauhkonen M, Lehto P, Lehtonen A, Louheranta A, Mannelin M, Martikkala V, Rastas M, Sundvall J, Turpeinen A, Viljanen T, Uusitupa M, Tuomilehto J: Prevention of Type II diabetes in subjects with impaired glucose tolerance: The Diabetes Prevention Study (DPS) in Finland. Study design and 1-year interim report on the feasibility of the lifestyle intervention programme. Diabetologia 42: 793-801, 1999
15. World Health Organization Study Group: Diabetes Mellitus, Geneva, Technical Report Series Number 727, 1985
16. Eriksson KF, Lindgarde F: Prevention of type 2 (non-insulin-dependent) diabetes mellitus by diet and physical exercise. The 6-year Malmo feasibility study. Diabetologia 34: 891-898, 1991
17. Pan XR, Li GW, Hu YH, Wang JX, Yang WY, An ZX, Hu ZX, Lin J, Xiao JZ, Cao HB, Liu PA, Jiang XG, Jiang YY, Wang JP, Zheng H, Zhang H, Bennett PH, Howard BV: Effects of diet and exercise in preventing NIDDM in people with impaired glucose tolerance. The Da Qing IGT and Diabetes Study. Diabetes Care 20:537-544, 1997
18. Uusitupa M, Siitonen O, Aro A, Pyörälä K: Prevalence of coronary heart disease, left ventricular failure and hypertension in middle-aged, newly diagnosed type 2 (non-insulin-dependent) diabetic subjects. Diabetologia 28: 22-27, 1985
19. Harris M: Undiagnosed NIDDM; clinical and public health issues. Diabetes Care 16: 642-652, 1993
20. Partanen J, Niskanen L, Lehtinen J, Mervaala E, Siitonen O, Uusitupa M: Natural history of peripheral neuropathy in patients with non-insulin-dependent diabetes mellitus. N Engl J Med 333: 89-94, 1995
21. Haffner S, Mykkänen L, Festa A, Burke J, Stern M: Insulin-resistant prediabetic subjects have more atherogenic risk factors than insulin-sensitive prediabetic subjects: implications for preventing coronary heart disease during prediabetic state. Circulation 101: 975-980, 2000